Christopher McFadden (San Francisco) joined KKR in 2018 and is a Managing Director focused on healthcare investing. Mr. McFadden works closely with the Private Markets Healthcare team to originate and execute a broad range of credit investment and third-party capital markets opportunities. Prior to joining KKR, Mr. McFadden was a Senior Advisor for Athyrium Capital Management. Previously, he was a Partner at Health Evolution Partners and a Managing Director at Goldman Sachs, where he was a member of the Americas Special Situations Group (AmSSG) focused on healthcare investing. Mr. McFadden holds a Bachelor’s degree from the University of Richmond and is a Chartered Financial Analyst (CFA).